Pharmaceutical composition for the treatment of the anemia of ma

Details Pharmaceutical composition for the treatment of the anemia of ma Pharmaceutical composition for the treatment of the anemia of ma

1986-02-03

1988-05-17

Rollins, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514814, A61K 3710

Patent

active

047450991

ABSTRACT:
A pharmaceutical composition for the treatment of the anemia of malignant tumors comprising a therapeutically effective amount of human erythropoietin (EPO) in a parenterally acceptable vehicle is disclosed. Human EPO may be extracted from human urine or also be prepared by expressing in a host cell the gene coding for the amino acid sequence of human EPO.

REFERENCES:
patent: 4254895 (1981-03-01), Fisher et al.
patent: 4303680 (1981-12-01), Takezawa et al.
Merck Index, 10th Edition, p. 533, No. 3632.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for the treatment of the anemia of ma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the treatment of the anemia of ma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of the anemia of ma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1881452